137 related articles for article (PubMed ID: 23646711)
1. Fabrication and characterization of photoluminescent silicon nanoparticles for drug delivery applications.
Ryu J; Cho B; Woo HG; Cho S; Sohn H
J Nanosci Nanotechnol; 2013 Jan; 13(1):157-60. PubMed ID: 23646711
[TBL] [Abstract][Full Text] [Related]
2. Smart particles for noble drug delivery system.
Park C; Kim J; Jang S; Woo HG; Ko YC; Sohn H
J Nanosci Nanotechnol; 2010 May; 10(5):3375-9. PubMed ID: 20358960
[TBL] [Abstract][Full Text] [Related]
3. Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide).
McInnes SJ; Irani Y; Williams KA; Voelcker NH
Nanomedicine (Lond); 2012 Jul; 7(7):995-1016. PubMed ID: 22394185
[TBL] [Abstract][Full Text] [Related]
4. General Reagent Free Route to pH Responsive Polyacryloyl Hydrazide Capped Metal Nanogels for Synergistic Anticancer Therapeutics.
Ujjwal RR; Purohit MP; Patnaik S; Ojha U
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11497-507. PubMed ID: 25961335
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and characterization of PSi smart particles containing 20(S)-camptothecin-functionalized germanium nanoparticles.
Jang S; Koh Y; Woo HG; Sohn H
J Nanosci Nanotechnol; 2011 Feb; 11(2):1328-32. PubMed ID: 21456181
[TBL] [Abstract][Full Text] [Related]
6. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs.
Secret E; Smith K; Dubljevic V; Moore E; Macardle P; Delalat B; Rogers ML; Johns TG; Durand JO; Cunin F; Voelcker NH
Adv Healthc Mater; 2013 May; 2(5):718-27. PubMed ID: 23203914
[TBL] [Abstract][Full Text] [Related]
7. Photoluminescence Enhancement of Silole-Capped Silicon Quantum Dots Based on Förster Resonance Energy Transfer.
Kim S; Kim S; Ko YC; Sohn H
J Nanosci Nanotechnol; 2015 Jul; 15(7):5057-61. PubMed ID: 26373077
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer.
Chiang YT; Yen YW; Lo CL
Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788
[TBL] [Abstract][Full Text] [Related]
9. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
Knežević NŽ; Lin VS
Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive Coating.
McInnes SJ; Szili EJ; Al-Bataineh SA; Vasani RB; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
Langmuir; 2016 Jan; 32(1):301-8. PubMed ID: 26654169
[TBL] [Abstract][Full Text] [Related]
11. Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
Yang Y; Zhang YM; Li D; Sun HL; Fan HX; Liu Y
Bioconjug Chem; 2016 Dec; 27(12):2834-2838. PubMed ID: 27998070
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery.
Liu D; Zhang H; Herranz-Blanco B; Mäkilä E; Lehto VP; Salonen J; Hirvonen J; Santos HA
Small; 2014 May; 10(10):2029-38. PubMed ID: 24616278
[TBL] [Abstract][Full Text] [Related]
13. Combination of iCVD and porous silicon for the development of a controlled drug delivery system.
McInnes SJ; Szili EJ; Al-Bataineh SA; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
ACS Appl Mater Interfaces; 2012 Jul; 4(7):3566-74. PubMed ID: 22720638
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and self-assembly of amphiphilic poly(acrylicacid)-poly(ɛ-caprolactone)-poly(acrylicacid) block copolymer as novel carrier for 7-ethyl-10-hydroxy camptothecin.
Djurdjic B; Dimchevska S; Geskovski N; Petrusevska M; Gancheva V; Georgiev G; Petrov P; Goracinova K
J Biomater Appl; 2015 Jan; 29(6):867-81. PubMed ID: 25209880
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery.
Meenach SA; Kim YJ; Kauffman KJ; Kanthamneni N; Bachelder EM; Ainslie KM
Mol Pharm; 2012 Feb; 9(2):290-8. PubMed ID: 22149217
[TBL] [Abstract][Full Text] [Related]
16. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
[TBL] [Abstract][Full Text] [Related]
17. Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.
Loch-Neckel G; Nemen D; Puhl AC; Fernandes D; Stimamiglio MA; Alvarez Silva M; Hangai M; Santos Silva MC; Lemos-Senna E
J Pharm Pharmacol; 2007 Oct; 59(10):1359-64. PubMed ID: 17910810
[TBL] [Abstract][Full Text] [Related]
18. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
19. Precision intracellular delivery based on optofluidic polymersome rupture.
Vasdekis AE; Scott EA; O'Neil CP; Psaltis D; Hubbell JA
ACS Nano; 2012 Sep; 6(9):7850-7. PubMed ID: 22900579
[TBL] [Abstract][Full Text] [Related]
20. Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy.
Zhai S; Hu X; Hu Y; Wu B; Xing D
Biomaterials; 2017 Mar; 121():41-54. PubMed ID: 28068593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
